D. E. Shaw & Co., Inc. Abbott Laboratories Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 50,929 shares of ABT stock, worth $5.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,929

Previous 9,855 416.78%

Holding current value

$5.26 Million

Previous $1.08 Million 433.95%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $4.5 Million - $4.97 Million	41,074 Added 416.78%	50,929 $5.79 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $11.8 Million - $14.4 Million	-130,858 Reduced 93.0%	9,855 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $31.4 Million - $37.6 Million	-328,432 Reduced 70.01%	140,713 $13.6 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $31.2 Million - $34.8 Million	-309,648 Reduced 39.76%	469,145 $51.1 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $31.3 Million - $36.9 Million	323,492 Added 71.05%	778,793 $78.9 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $78.5 Million - $92.1 Million	-825,754 Reduced 64.46%	455,301 $50 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $33.6 Million - $38.9 Million	-346,803 Reduced 21.3%	1,281,055 $124 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $74.1 Million - $89.6 Million	-726,020 Reduced 30.84%	1,627,858 $177 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $200 Million - $244 Million	1,757,136 Added 294.45%	2,353,878 $279 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $12.4 Million - $15.2 Million	-107,350 Reduced 15.25%	596,742 $84 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $173 Million - $192 Million	-1,486,607 Reduced 67.86%	704,092 $83.2 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $49.1 Million - $57.8 Million	463,759 Added 26.85%	2,190,699 $254 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $17.6 Million - $20.8 Million	162,007 Added 10.35%	1,726,940 $207 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $69.1 Million - $75.3 Million	658,128 Added 72.58%	1,564,933 $171 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $82.3 Million - $100 Million	898,205 Added 10444.24%	906,805 $98.7 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $283,309 - $362,600	-3,700 Reduced 30.08%	8,600 $786,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $619,530 - $905,923	9,862 Added 404.51%	12,300 $971,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $498,774 - $555,252	-6,353 Reduced 72.27%	2,438 $212,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $573,616 - $621,978	-7,009 Reduced 44.36%	8,791 $736,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $13.4 Million - $16.2 Million	-220,809 Reduced 93.32%	15,800 $1.16 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $10.6 Million - $11.8 Million	184,967 Added 358.17%	236,609 $14.4 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $136,904 - $154,787	-2,433 Reduced 4.5%	51,642 $3.1 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $2.48 Million - $2.66 Million	46,235 Added 589.73%	54,075 $3.09 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $376,790 - $420,537	7,840	7,840 $418,000

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account